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Worsening confusion in a patient with HIV and a normal CD4 count. 
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Abstract 
 
Rapidly progressive encephalopathy in the HIV-positive patient can present a major diagnostic and 
management challenge. We report a case of CD8+ encephalitis, a severe but treatable form of HIV-
related acute encephalopathy, in a patient with normal CD4 count and undetectable serum viral load. 
CD8+ encephalitis is characterised by diffuse perivascular and intraparenchymal CD8+ lymphocytic 
infiltration and can occur in patients apparently stable on antiretroviral treatment, likely due to viral 
escape into the CNS. Even following severe encephalopathy with a very poor initial neurological 
status, treatment including high-dose corticosteroids can lead to a favourable prognosis and an 
excellent neurological outcome, as in our patient.   
 
 
Case history 
 
A 52 year old black African woman with known HIV infection presented to her local hospital with a 3-
week progressive history of confusion, drowsiness, poor balance and mild headache. Three weeks 
prior to the onset of symptoms, she had returned from a four week holiday in Sub-Saharan Africa. 
During her holiday she was neurologically well but received antibiotics for a transient cellulitis, having 
cut her shin while climbing out of a bus. Soon after her return she became confused and 
disorientated, wandering at night and confabulating. There were no fevers, seizures, weakness or 
sensory loss.  
She was found to be HIV positive 8 years previously but did not present for treatment until 18 months 
prior to this illness, when combined antiretroviral therapy (cART) was started. On initiation, CD4 count 
was 550 cells/µL (normal: 500-1500) and plasma HIV viral load was 850000 copies/mL. Her cART on 
admission included tenofovir, emricitabine, ritonavir and atazanavir and had not been altered for the 
past year. She had been fully compliant with her medication and had missed no doses during her 
holiday. Two months prior to her admission, HIV was undetectable in plasma with a CD4 count of 870 
cells/µL. There was no previous history of significant HIV-related complications. She had a past 
history of treated syphilis many years ago but no other significant illness. She was born in Sub-
Saharan Africa but lived in the UK for 15 years and  was fully independent prior to her illness, in full 
time employment. She was a non-smoker with moderate alcohol intake. There was no relevant family 
history. 
On initial examination she was afebrile and normotensive, able to obey commands but disorientated 
to time and place. She was noted to have a left pronator drift and bilateral extensor plantars. Tone, 
power, reflexes and sensory examination were otherwise normal. General systems examination was 
also normal. A CT brain scan showed generalised sulcal effacement indicative of brain swelling and 
confluent white matter hypoattenuation. Blood tests showed CRP 6 mg/l, normal WBC (8.4 x109/L) 
and unremarkable liver and renal function. She deteriorated quickly following her admission, 
becoming drowsy and unable to follow commands. Three days after her initial presentation, she was 
incontinent of urine, was noted to have right arm weakness and her Glasgow Coma Score (GCS) 
dropped to 10/15. Repeat CT imaging showed worsening cerebral oedema and she was started on 
Dexamethasone 4mg QDS, IV acyclovir and ceftriaxone. She was urgently transferred to our tertiary 
neurological centre for further management. She was intubated at the time of transfer and was 
admitted directly to our Intensive Care Unit.  
An MRI head was performed, which demonstrated diffuse and symmetrical T2 hyperintense signal 
abnormality throughout the cerebral white matter, with some additional involvement of deep grey 
structures and infratentorial white matter. Striking diffusion restriction was observed, predominantly 
along the periphery of the confluent white matter changes (Figure 1). Her CD4 count was 220 cells/µL 
(lowest documented during her admission), CD8 count was 360 cells/µL (normal 150 – 1000) and HIV 
RNA was undetectable in plasma. Investigations for possible infective causes were all negative. 
Lumbar puncture was contraindicated due to raised intracranial pressure at that point.  
Intermittent lower limb jerking was noted during her admission and an EEG showed generalised 
slowing consistent with widespread cortical dysfunction, right posterior background suppression, and 
right frontal sharp waves suggestive of focal cortical irritability: she was started on phenytoin for 
presumed seizures. However, despite treatment she continued to deteriorate and her GCS dropped to 
4. In view of ongoing deterioration in the absence of a confirmed diagnosis, we proceeded to a biopsy 
of the non-dominant frontal lobe in accordance with the MRI findings, with collection of cerebrospinal 
fluid (CSF) through the burr hole at the end of the procedure. Histopathology showed a widespread 
lymphocytic meningoencephalitis characterised by diffuse CD8+ T-lymphocyte infiltrate predominantly 
in the white matter but also in the grey matter and meninges (Figure 2). There was no evidence of 
progressive multifocal leukoencephalopathy (PML), demyelinating disorder, vasculitis or 
granulomatous inflammation on histology. Immunohistochemistry for virus (JC, HSV1/2, HIV) and for 
toxoplasma was negative. No micro-organisms were detected on special stains to suggest any 
infection. In addition, CSF collected during the biopsy demonstrated 1100 HIV copies/mL. 
Parenchymal leakage of HIV into CSF cannot be ruled out but was felt unlikely in the absence of 
detectable virus within the brain. 
Her cART regimen was modified to include raltegravir to achieve better CNS penetration and 
dexamethasone was increased to 8mg TDS. However, she remained comatose, with no evidence of 
improvement four weeks after admission; at this point a poor prognosis was anticipated, thus 
following family discussions a decision was made to withdraw treatment. However, she failed to 
tolerate extubation and then showed evidence of neurological improvement, with spontaneous eye 
opening and tracking; treatment with antiretrovirals and steroids was reinstated.  
She continued to improve and 6 weeks after her admission she was successfully extubated. One 
week later she was discharged from ITU to a neurological ward where she continued to improve in 
alertness and cognition. Lumbar puncture was considered safe at this point, and CSF contained 5 
lymphocytes /mm3, protein 0.44 g/L, glucose 5.1 mmol/L (serum 6.5), while HIV RNA was 
undetectable. Oligoclonal bands were present in both CSF and serum, a non-specific finding 
consistent with HIV positive status1. A repeat MRI showed improvement of the diffuse widespread 
signal abnormality involving the cerebral subcortical and deep white matter, with almost complete 
resolution of the diffusion restriction and no evidence of cerebral oedema. At 8 weeks from her initial 
presentation, she was orientated in time and place and responding to questions appropriately. 
Asymmetrical limb weakness and hyporeflexia was noted at this point, and neurophysiology was 
suggestive of a critical illness neuromyopathy (low amplitude CMAPs with prolonged duration, 
myopathic EMG changes). A CD8-related vasculitis was considered unlikely as a cause for the 
neuropathy, as it was symmetrical, length-dependent and painless: since this was clinically self-
limiting a nerve biopsy was not undertaken. She was transferred to our Neurorehabilitation Unit and 
continued to improve functionally with multidisciplinary rehabilitation: at 18 weeks she was able to 
transfer unaided and walk with 2 sticks. Cognition also improved, with an increase in her Montreal 
Cognitive Assessment score from 16/30 (corrected for time in education) to 25/30 over the course of 
her admission. She was discharged to her own home, and when reviewed 4 months later, her motor 
system was intact, she was entirely independent and considering a return to work. 
 
Discussion 
 
Differential diagnosis 
Our patient had a diagnosis of CD8+ encephalitis, a severe but treatable form of HIV-related acute 
encephalopathy. On initial presentation the history of subacute confusion in the context of known HIV 
infection raised a number of potential differential diagnoses, mainly opportunistic infections and 
neoplasms secondary to immunodeficiency. However our patient’s CD4 count in combination with the 
MRI appearances effectively discounted many of the ‘usual suspects’, including lymphoma, 
cryptococcosis, toxoploasmosis, tuberculosis, cytomegalovirus encephalitis and progressive 
multifocal leukoencephalopathy (PML). Primary CNS vasculitis2 can be associated with HIV, 
sometimes in the context of opportunistic infection and  can present with encephalopathy, but 
neuroimaging and histopathology were not in keeping with this in our patient with no evidence of 
vessel narrowing or irregularity. Likewise an immune reconstitution inflammatory syndrome (IRIS) was 
considered but was felt to be unlikely in the absence of contrast enhancement3. HIV can itself present 
with an encephalitis, usually acutely in patients with poorly controlled infection and a high peripheral 
viral load; our patient’s infection was well controlled, and the presence of a detectable HIV viral load in 
the CSF but not in plasma or brain parenchyma would also be more consistent with CD8+ 
encephalitis than with primary HIV encephalitis. An encephalitis may be seen in the context of HIV 
compartmentalisation, whereby cell type-specific differences in viral replication and variations in anti-
retroviral drug concentrations lead to differential selection pressures and the evolution of a distinct 
HIV sub-population within the CNS4 This is usually associated with significantly higher CSF viral loads 
and a cellular CSF however and was not felt to be likely in this case. 
We also considered causes of encephalopathy unrelated to HIV; the peripheral restriction of diffusion 
on MRI was potentially suggestive of toxic demyelination5,6. However, there was no history of 
recreational drug abuse, exposure to toxins, radiotherapy, or immunosuppressant medication that can 
cause this picture5,6. Common metabolic causes of acute confusion including systemic infections were 
quickly excluded. Common CNS infections seen outside the context of HIV were also considered and 
the patient was treated empirically for HSV encephalitis and bacterial meningitis. The recent travel 
history raised the possibility of malaria or viral haemorrhagic fevers, and these were tested for and 
excluded.  
CD8 encephalitis  
The typical clinical presentation of CD8+ encephalitis is that of progressive cognitive impairment, 
headache and seizures7. CSF typically reveals CD8 lymphocytosis and high HIV viral load7. MRI 
shows characteristic changes: diffuse T2 hyperintensities predominantly in the white, but also in the 
gray matter, and multiple gadolinium-enhancing perivascular lesions which show restriction on 
diffusion-weighted imaging7. The histopathological hallmark is diffuse perivascular and 
intraparenchymal CD8+ lymphocytic infiltration and reactive astrocytosis, with inconsistent and weak 
expression of HIV protein p24 and absence of multinucleated giant cells and CD4+ cells7,8. This 
perivascular infiltration may be detected on post-contrast T1 spin echo MRI imaging, and it is 
important that this sequence is included in HIV-positive patients with encephalopathy. While in a 
minority of cases CD8+ encephalitis may develop soon after first initiation of cART, with histological 
features of an Immune Reconstitution Inflammatory Syndrome (IRIS), CD8+ encephalitis is mostly 
seen as an unexpected occurrence in patients who are stable on treatment. In these cases there is 
usually a history of brief treatment interruption or minor intercurrent infection. The common feature 
between causal groups may be the novel introduction of the HIV virus into the CNS, and one might 
suggest that intercurrent infection in a stable patient may provide the immune ‘distraction’ that allows 
such viral escape to occur. Our patient had a normal CD4 count with fully suppressed HIV two months 
prior to presentation, and it seems likely that the episode of cellulitis during her trip to Africa may have 
been important. Why transient CNS viral escape should provoke such a severe inflammatory 
response in some patients and not others is an interesting question, and is likely to be explained at 
least in part by genetic factors. HIV compartmentalisation may itself be considered a chronic form of 
viral escape, usually responsive to changing anti-retroviral drug to achieve greater CNS penetrance, 
but would not be associated with a prominent CD8+ infiltrate. Brain biopsy in IRIS typically also shows 
CD68+ macrophage and CD8+ T-cell infiltrates as well as necrotic changes9, a similar picture to that 
of CD8+ encephalitis, and there is clinical and histopathological overlap between the two entities. 
In a case series by Lescure et al, 14 patients with CD8+ encephalitis received treatment with high-
dose corticosteroids, yet outcome was variable: 5 made a complete recovery, 4 survived with 
significant residual cognitive impairment, and 5 died7.  Of the 5 patients within that series who 
required ITU care during  their illness, 3 died and 2 had residual cognitive impairment. Our patient is 
remarkable in that despite diffuse marked cerebral oedema, profound coma and what was felt to be a 
poor prognosis, she went on to make an almost full recovery following a period of neurorehabilitation.   
The differential diagnosis of acute encephalopathy in the HIV-positive patient is wide and can be 
challenging. CD8+ encephalitis is a treatable CNS complication of HIV: if this is suspected then with 
early diagnosis (by brain biopsy if necessary) and steroid treatment its prognosis can be favourable 
even in the face of severe and apparently persistent encephalopathy, as in our patient.  
 
 
 
 
 
 
 
 
 
 
Key Points 
 CD8+ encephalitis should be considered in 
the differential diagnosis of acute confusion 
in the HIV-positive patient, particularly if CD4 
count is normal  
 Consider early biopsy in HIV-positive patients 
with encephalopathy of uncertain cause 
 MRI may show diffuse T2 hyperintensities 
and multiple gadolinium-enhancing 
perivascular lesions with restriction on 
diffusion-weighted imaging Including a post-
contrast T1 spin echo sequence in MRI 
scanning may aid diagnosis 
 Early treatment with high-dose steroids when 
this diagnosis is suspected is essential for a 
favourable outcome 
 Prognosis is variable but can be favourable 
even following severe encephalopathy  
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Figure 1. 
(A) MRI (axial T2 weighted images) demonstrating confluent white matter hyperintensity with extension into the 
thalami and basal ganglia. 
(B) MRI (diffusion weighted imaging)  
B1000 images and ADC maps demonstrating restricted diffusion (corresponding dark ADC signal) peripherally 
with free diffusion (increased ADC signal)  towards the centre of the confluent T2 hyperintense areas 
 
Figure 2.  
CD8+ lymphocytic meningoencephalitis. Brain biopsy of the non-dominant frontal lobe revealed (A) 
Perivascular cuff of lymphocytes with diffusely scattered single lymphocytes in the parenchyma (with high power 
view in the inset), (B) The lymphocytes were predominantly CD4+ T-lymphocytes among which the vast majority 
of them expressed CD8 (with high power view in the inset). There was associated macrophage infiltrate (C) and 
reactive gliosis (D) as seen on CD68 and GFAP respectively. There was no demyelination, infection, 
granulomatous inflammation or vasculitis. The features supported CD8 encephalitis in view of the clinical history. 
 
